Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
To explore guidelines on the use of MRI and PET/CT monitoring primary tumor response to neoadjuvant chemotherapy (NAC), taking breast cancer subtype into account.In this prospective cohort study, 188 women were included with stages II and III breast cancer. MRI and 18F-FDG-PET/CT were acquired befor...
Главные авторы: | , , , , , , , , , , , |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Public Library of Science (PLoS)
2017-01-01
|
Серии: | PLoS ONE |
Online-ссылка: | http://europepmc.org/articles/PMC5439668?pdf=render |